News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ISTO Technologies, Inc. Initiates Phase II Trial of NuQu®: Novel Cell-Based Therapy for the Treatment of Painful Spinal Discs


10/22/2012 9:16:09 AM

ST. LOUIS, Oct. 22, 2012 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc. announced today that it is initiating a Phase II trial to further evaluate the efficacy and safety of its NuQu® cell-based therapy for the treatment of pain and disability associated with degenerated spinal discs. The company expects to commence enrollment in the randomized, double-blinded, placebo-controlled trial in the fourth quarter of 2012. Interim results are expected by the end of 2013.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES